scholarly journals Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes.

2009 ◽  
Vol 56 (2) ◽  
Author(s):  
Włodzimierz Łuczyński ◽  
Natalia Wawrusiewicz-Kurylonek ◽  
Anna Stasiak-Barmuta ◽  
Remigiusz Urban ◽  
Elzbieta Iłendo ◽  
...  

Diabetes mellitus is one of the most common chronic diseases in children. T regulatory cells (Tregs) modulate response to autoantigens and probably play a role in pathogenesis of type 1 diabetes (T1DM). The aim of the present study was the assessment of T regulatory cells including their percentages and expression of critical genes in these cells in children with newly diagnosed type 1 diabetes. The examined group consisted of 50 children with T1DM. A flow cytometric analysis of T-cell subpopulations was performed using the following markers: anti-CD4, anti-CD25 and anti-CD127 (=IL-7R). Additionally, T regulatory cells were isolated for assessment of mRNA levels for chosen genes with the real-time RT-PCR technique. The percentages of CD4(+)CD25(high)CD127(dim/-) were very low and did not differ between T1DM and control children. We did not observe any statistically significant differences between healthy and diabetic children in mRNA expression for FoxP3, IL-7R (CD127), IL-8RA, IL-10RA, IL-12A, IL-2RA (CD25), IL-21, STAT1, STAT3, SOCS2, SOCS3, TGF-beta1-R1, TGF-beta-R2 and TBX-21 genes. Interestingly the mRNA level for CTLA-4, ICOS1, IL-23, IL-27, SMAD3 and GITR were lower in Treg cells of children with diabetes compared to the control patients. No disturbances in the percentages of T regulatory cells in patients with diabetes but diminished expression of some elements important in Treg function could be the result of an immunologic imbalance accompanying the onset of the diabetes. The results of our study should be used in future research in the field of immunotherapy in pediatric diabetes.

2011 ◽  
Vol 120 (02) ◽  
pp. 101-109 ◽  
Author(s):  
W. Łuczyński ◽  
N. Wawrusiewicz-Kurylonek ◽  
A. Szypowska ◽  
E. Iłendo ◽  
A. Bossowski ◽  
...  

AbstractThere is increasing evidence that T-regulatory (Treg) cells could be used to prevent or cure autoimmune diseases including type 1 diabetes mellitus (T1DM). The aim of the present study was to verify the hypothesis that functional Treg cells can be generated from conventional T-cells separated from a small amount of peripheral blood of children with newly diagnosed T1DM (N=25).CD4+CD25- cells were cultured with Treg expander (CD3/CD28) and IL-2 for generating de novo Treg cells. The assessment of the expression of selected genes and proteins critical to Treg function and the proliferation assays were performed with the use of real-time RT-PCR and flow cytometry.After a 4-week stimulation with Treg expander and IL-2, the percentage of T-regulatory cells was significantly higher compared to the cells treated with medium alone (with no difference between diabetic and control children). However, we found some disturbances in the gene expression at mRNA level for molecules crucial for T-reg function. The induced Tregs from diabetic and control children were fully functional as assessed in proliferation assays.despite some disturbances at mRNA level in the critical gene expression, the suppressive properties of induced Treg cells from diabetic and control children were effective.


PLoS ONE ◽  
2019 ◽  
Vol 14 (1) ◽  
pp. e0210839 ◽  
Author(s):  
Marsha Pellegrino ◽  
Antonino Crinò ◽  
Manuela M. Rosado ◽  
Alessandra Fierabracci

2015 ◽  
Vol 98 ◽  
pp. 22-30 ◽  
Author(s):  
Basset ElEssawy ◽  
Xian C. Li

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 227-LB
Author(s):  
RAHUL SHARMA ◽  
VIKRAM SABAPATHY

Sign in / Sign up

Export Citation Format

Share Document